Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
DAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 HKD | -1.67% | -2.48% | +12.38% |
03-26 | Dawnrays Pharmaceutical Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 June 2024 | CI |
03-25 | Dawnrays' 2023 Profit Falls 9% on Lower Revenue | MT |
1st Jan change | Capi. | |
---|---|---|
+12.38% | 231M | |
+38.69% | 728B | |
+34.28% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+17.02% | 244B | |
+9.31% | 207B | |
-5.07% | 205B | |
-0.35% | 163B |
- Stock Market
- Equities
- 2348 Stock
- News Dawnrays Pharmaceutical (Holdings) Limited
- Dawnrays Pharmaceuti : Voluntary Announcement New Product Pharmaceutical Registration Approval